6-bromo-3-methyl-3,4-dihydro-2(1H)-quinazolinone, 95.0%, 250mg

2-(2-(2-(2-(4-(6-Methyl-1,2,4,5-tetrazin-3-yl)phenoxy)ethoxy)ethoxy)ethoxy)ethanamine hydrochloride, 97%, 50mg

4-(Morpholinomethyl)benzonitrile, 95.0%, 1g

5-Bromo-1-benzofuran-3-carboxylic acid, 95+%, 2.5g

Methyl 4-Methoxy-2-methylbenzoate>98.0%(GC)5g

3,4-Dihydro-8-nitro-2H-1,4-benzoxazine, 250mg

2-METHYL-1,3-DIOXOLANE-2-ETHANOL, 95.0%, 5g

TERT-BUTYL 3,3-DIFLUOROCYCLOBUTANECARBOXYLATE, 95.0%, 1g

9H-Pyrido[3',2':3,4]cyclopenta[1,2-b]pyridin-9-one, 97.0%, 5g

Acido L-Aspartico, Min. 98,5%, Ph. Eur., per Biochimica, 500 g, confezione in plastica.

(3R)-3-(propan-2-yl)pyrrolidine hydrochloride, 95.0%, 100mg

2-Hydroxy-3-methyl-5-nitropyridine, 95.0%, 1g

4-(Piperazine-1-carbonyl)-benzoic acid, 98.0%, 5g